About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Spironolactone
- Procedure number
- PSUSA/00002780/202103
- Regulatory outcome
- Variation
Documents
Spironolactone: List of nationally authorised medicinal products - PSUSA/00002780/202103
English (EN) (162.23 KB - PDF)
Spironolactone: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002780/202103
English (EN) (76.22 KB - PDF)
български (BG) (77.63 KB - PDF)
español (ES) (76.24 KB - PDF)
čeština (CS) (75.79 KB - PDF)
dansk (DA) (75.3 KB - PDF)
Deutsch (DE) (80.23 KB - PDF)
eesti keel (ET) (69.73 KB - PDF)
ελληνικά (EL) (76.05 KB - PDF)
français (FR) (85.33 KB - PDF)
hrvatski (HR) (82.06 KB - PDF)
íslenska (IS) (77.65 KB - PDF)
italiano (IT) (94.77 KB - PDF)
latviešu valoda (LV) (90.28 KB - PDF)
lietuvių kalba (LT) (82.21 KB - PDF)
magyar (HU) (75.57 KB - PDF)
Malti (MT) (104.34 KB - PDF)
Nederlands (NL) (74.92 KB - PDF)
norsk (NO) (75.24 KB - PDF)
polski (PL) (96.79 KB - PDF)
português (PT) (94.5 KB - PDF)
română (RO) (72.88 KB - PDF)
slovenčina (SK) (77.79 KB - PDF)
slovenščina (SL) (73.85 KB - PDF)
Suomi (FI) (72.18 KB - PDF)
svenska (SV) (84.79 KB - PDF)